PLURI INC (PLUR)
US72942G2030 - Common Stock
PLUR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 587 industry peers in the Biotechnology industry. PLUR may be in some trouble as it scores bad on both profitability and health. PLUR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year PLUR has reported negative net income.
PLUR had a negative operating cash flow in the past year.
In the past 5 years PLUR always reported negative net income.
In the past 5 years PLUR always reported negative operating cash flow.
1.2 Ratios
PLUR's Return On Assets of -58.64% is in line compared to the rest of the industry. PLUR outperforms 42.05% of its industry peers.
Looking at the Return On Equity, with a value of -554.10%, PLUR is doing worse than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -58.64% | ||
| ROE | -554.1% | ||
| ROIC | N/A |
ROA(3y)-56.99%
ROA(5y)-65.64%
ROE(3y)-147.07%
ROE(5y)-131%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 78.87%, PLUR belongs to the top of the industry, outperforming 87.01% of the companies in the same industry.
In the last couple of years the Gross Margin of PLUR has remained more or less at the same level.
PLUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.87% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.16%
GM growth 5Y-0.7%
2. Health
2.1 Basic Checks
PLUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PLUR has more shares outstanding
Compared to 5 years ago, PLUR has more shares outstanding
PLUR has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -14.39, we must say that PLUR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of PLUR (-14.39) is worse than 83.08% of its industry peers.
PLUR has a Debt/Equity ratio of 5.55. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of PLUR (5.55) is worse than 84.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.55 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -14.39 |
ROIC/WACCN/A
WACC7.28%
2.3 Liquidity
A Current Ratio of 7.12 indicates that PLUR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 7.12, PLUR is in the better half of the industry, outperforming 68.03% of the companies in the same industry.
PLUR has a Quick Ratio of 7.12. This indicates that PLUR is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 7.12, PLUR is doing good in the industry, outperforming 68.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.12 | ||
| Quick Ratio | 7.12 |
3. Growth
3.1 Past
PLUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.37%.
The Revenue has grown by 10.94% in the past year. This is quite good.
Measured over the past years, PLUR shows a very strong growth in Revenue. The Revenue has been growing by 42.13% on average per year.
EPS 1Y (TTM)-37.37%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-277.97%
Revenue 1Y (TTM)10.94%
Revenue growth 3Y143.85%
Revenue growth 5Y42.13%
Revenue growth Q2QN/A
3.2 Future
Based on estimates for the next years, PLUR will show a very strong growth in Earnings Per Share. The EPS will grow by 38.56% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y4%
EPS Next 2Y38.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for PLUR. In the last year negative earnings were reported.
Also next year PLUR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as PLUR's earnings are expected to grow with 38.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.56%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for PLUR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PLURI INC
NASDAQ:PLUR (5/8/2024, 2:46:21 PM)
5.87
-0.02 (-0.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap31.64M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -58.64% | ||
| ROE | -554.1% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.87% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.55 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 7.12 | ||
| Quick Ratio | 7.12 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-37.37%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y4%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)10.94%
Revenue growth 3Y143.85%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y